Activities per year
The RESCEU project aims to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics.
|Effective start/end date||01/01/2018 → 31/12/2020|
Maarten van Wijhe (Speaker)
11 Sep 2019
Activity: Talk or presentation › Lecture and oral contribution